Molecular Templates Gestione
Gestione criteri di controllo 2/4
Molecular Templates Il CEO è Eric Poma, nominato in Jan2009, e ha un mandato di 15.83 anni. la retribuzione annua totale è $ 857.77K, composta da 72.4% di stipendio e 27.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.28% delle azioni della società, per un valore di $ 7.43K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.3 anni e 7.3 anni.
Informazioni chiave
Eric Poma
Amministratore delegato
US$857.8k
Compenso totale
Percentuale dello stipendio del CEO | 72.4% |
Mandato del CEO | 15.8yrs |
Proprietà del CEO | 0.3% |
Durata media del management | 1.3yrs |
Durata media del Consiglio di amministrazione | 7.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 30% Share Price Rise
Oct 10Earnings Release: Here's Why Analysts Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Price Target To US$18.00
Aug 17Molecular Templates, Inc.'s (NASDAQ:MTEM) Shares Bounce 27% But Its Business Still Trails The Industry
Jul 30Little Excitement Around Molecular Templates, Inc.'s (NASDAQ:MTEM) Revenues As Shares Take 48% Pounding
Apr 03Lacklustre Performance Is Driving Molecular Templates, Inc.'s (NASDAQ:MTEM) 26% Price Drop
Dec 20There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 45% Share Price Rise
Apr 17What Does The Future Hold For Molecular Templates, Inc. (NASDAQ:MTEM)? These Analysts Have Been Cutting Their Estimates
Nov 16Time To Worry? Analysts Are Downgrading Their Molecular Templates, Inc. (NASDAQ:MTEM) Outlook
Aug 14Molecular Templates GAAP EPS of -$0.44 misses by $0.01, revenue of $4.42M misses by $2.6M
Aug 11Rock star Growth Puts Molecular Templates (NASDAQ:MTEM) In A Position To Use Debt
Apr 29Health Check: How Prudently Does Molecular Templates (NASDAQ:MTEM) Use Debt?
Dec 30Some Analysts Just Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates
Nov 25Is Molecular Templates (NASDAQ:MTEM) Using Debt In A Risky Way?
Sep 22News Flash: Analysts Just Made A Notable Upgrade To Their Molecular Templates, Inc. (NASDAQ:MTEM) Forecasts
Aug 15Need To Know: Analysts Just Made A Substantial Cut To Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates
May 18Brokers Are Upgrading Their Views On Molecular Templates, Inc. (NASDAQ:MTEM) With These New Forecasts
Mar 21Need To Know: The Consensus Just Cut Its Molecular Templates, Inc. (NASDAQ:MTEM) Estimates For 2021
Feb 21Is Molecular Templates (NASDAQ:MTEM) A Risky Investment?
Jan 26Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$16m |
Mar 31 2024 | n/a | n/a | -US$18m |
Dec 31 2023 | US$858k | US$621k | -US$8m |
Sep 30 2023 | n/a | n/a | -US$26m |
Jun 30 2023 | n/a | n/a | -US$47m |
Mar 31 2023 | n/a | n/a | -US$60m |
Dec 31 2022 | US$2m | US$600k | -US$93m |
Sep 30 2022 | n/a | n/a | -US$81m |
Jun 30 2022 | n/a | n/a | -US$87m |
Mar 31 2022 | n/a | n/a | -US$78m |
Dec 31 2021 | US$4m | US$577k | -US$83m |
Sep 30 2021 | n/a | n/a | -US$101m |
Jun 30 2021 | n/a | n/a | -US$94m |
Mar 31 2021 | n/a | n/a | -US$110m |
Dec 31 2020 | US$5m | US$560k | -US$105m |
Sep 30 2020 | n/a | n/a | -US$92m |
Jun 30 2020 | n/a | n/a | -US$107m |
Mar 31 2020 | n/a | n/a | -US$85m |
Dec 31 2019 | US$2m | US$515k | -US$69m |
Sep 30 2019 | n/a | n/a | -US$60m |
Jun 30 2019 | n/a | n/a | -US$27m |
Mar 31 2019 | n/a | n/a | -US$28m |
Dec 31 2018 | US$4m | US$500k | -US$30m |
Sep 30 2018 | n/a | n/a | -US$31m |
Jun 30 2018 | n/a | n/a | -US$36m |
Mar 31 2018 | n/a | n/a | -US$31m |
Dec 31 2017 | US$3m | US$448k | -US$24m |
Compensazione vs Mercato: La retribuzione totale di Eric ($USD 857.77K ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 646.00K ).
Compensazione vs guadagni: La retribuzione di Eric è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Eric Poma (52 yo)
15.8yrs
Mandato
US$857,769
Compensazione
Dr. Eric E. Poma, Ph D., is the Chief Executive Officer and Chief Scientific Officer of Molecular Templates, Inc. since 2009 and served as its President. Dr. Poma founded Private Molecular in February 2009...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO, Chief Scientific Officer & Director | 15.8yrs | US$857.77k | 0.28% $ 7.4k | |
President | 1.8yrs | US$579.24k | 0.097% $ 2.6k | |
Chief Operating Officer | 1.3yrs | Nessun dato | Nessun dato | |
Chief Strategy Officer & Head of IR | 1.3yrs | Nessun dato | Nessun dato | |
Senior Vice President & General Counsel | less than a year | Nessun dato | Nessun dato | |
Senior VP & Head of CMC Development | no data | Nessun dato | Nessun dato | |
Senior VP and Head of Preclinical Development & Translational Medicine | less than a year | Nessun dato | Nessun dato |
1.3yrs
Durata media
52yo
Età media
Gestione esperta: Il team dirigenziale di MTEM non è considerato esperto (durata media 1.3 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO, Chief Scientific Officer & Director | 7.3yrs | US$857.77k | 0.28% $ 7.4k | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 7.3yrs | US$59.29k | 0% $ 0 | |
Independent Chairman | 7.3yrs | US$87.29k | 0.041% $ 1.1k | |
Independent Director | 7.3yrs | US$54.29k | 0% $ 0 | |
Independent Director | 4.9yrs | US$49.29k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Director | 2.7yrs | US$561.35k | 0% $ 0 |
7.3yrs
Durata media
67yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MTEM sono considerati esperti (durata media dell'incarico 7.3 anni).